Ergotamine Tartrate

酒石酸麦角胺

Report date: 2022/05/18 17:41:14
NME

Base Information

Drug NameErgotamine Tartrate
Drug Alias Name麦角胺酒石酸盐麦角胺Ergostat
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor agonistsAdrenergic receptor alpha-1 agonistsSerotonin (5-HT) receptor partial agonists
TargetsAdrenergic receptors alpha-1Serotonin (5-HT) receptorDopamine D2 receptor
Therapy Area/IndicationsCluster HeadacheMigraine Disorders
Global Approved IndicationsCluster HeadacheMigraine Disorders
Approved Indications in ChinaCluster HeadacheMigraine Disorders
Original Approved Country/TerritoryN/A
Original Approved Date1921/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesTeva Czech Industries Sro Llc
Inactive CompaniesN/A
Active IndicationsCluster HeadacheMigraine Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN02CA02
Related LinksWikipediaDrugBankKEGG